Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Metadata
Title
Proarrhythmic Potential of Antimicrobial Agents
Authors
J. Simkó
A. Csilek
J. Karászi
I. Lőrincz
Publication date
01-06-2008
Publisher
Urban & Vogel
Published in
Infection / Issue 3/2008
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-007-7211-8

Other articles of this Issue 3/2008

Infection 3/2008 Go to the issue

Case Report

Disseminated Tuberculosis Following Total Knee Arthroplasty in an HIV Patient

Correspondence

Teicoplanin-Induced Complete AV-Block in a Heart Transplant Recipient

Clinical and Epidemiological Study

The Time Course of Blood C-reactive Protein Concentrations in Relation to the Response to Initial Antimicrobial Therapy in Patients with Sepsis

Editorial

Treatment of Infectious Diseases – Taking Unexpected Drug Effects into Consideration

Clinical and Epidemiological Study

Monocyte Phagocytosis of Viable Staphylococcus aureus is Impaired by Barbiturates, but not by Propofol

Clinical and Epidemiological Study

Evaluation of Toluidine Blue O Staining for the Diagnosis of Pneumocystis jiroveci in Expectorated Sputum Sample and Bronchoalveolar Lavage from HIV-infected Patients in a Tertiary Care Referral Center in Ethiopia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits